Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 6 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Syndicated Law PC has 386 career applications in Biotechnology & Pharmaceuticals and 9 pending office actions. The record reflects an established application history alongside a current office-action docket that remains active.
The resolved allowance rate is 90.13%, and the average is 2.78 office actions per allowance. The outcome measure shows that resolved matters have commonly reached allowance, while the activity measure indicates that allowances generally followed more than one office-action event.
Practitioners can use the profile to evaluate both reported results and the level of prosecution interaction associated with allowances. The data does not explain differences among applications, claim strategies, or examiner treatment, so it should be used as a screening tool rather than a matter-specific prediction.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §112 only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERCADO VARGAS, ARIEL | 1 | 71.5% | +28.3% |
| COX, NATISHA D | 1 | 72.9% | +21.4% |
| BRANDSEN, BENJAMIN MICHAEL | 1 | 60.9% | +21.7% |
| TAKENAKA, RISA | 1 | 26.1% | +100.0% |
| HIBSHMAN, SARAH GRACE | 1 | 38.2% | +40.7% |
| TINSLEY, BRENDAN THOMAS | 1 | 60.4% | +74.3% |
| ROGERS, ERIC JASON | 1 | 56.9% | +33.2% |
| PENNINGTON, KATIE LEIGH | 1 | 31.8% | +58.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | ROGERS, ERIC JASON | 112d overdue |
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | — |
| 18027892 | CELL POPULATION PRODUCTION METHOD | TAKENAKA, RISA | — |
| 18001994 | BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE | HIBSHMAN, SARAH GRACE | — |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | TINSLEY, BRENDAN THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | ROGERS, ERIC JASON | 112d overdue |
| 18766372 | Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction | COX, NATISHA D | 70d |
| 18780967 | USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS | MERCADO VARGAS, ARIEL | — |
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | — |
| 18027892 | CELL POPULATION PRODUCTION METHOD | TAKENAKA, RISA | — |
| 18001994 | BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE | HIBSHMAN, SARAH GRACE | — |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | TINSLEY, BRENDAN THOMAS | — |
| 17601861 | CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY | PENNINGTON, KATIE LEIGH | — |
| Client (Assignee) | Pending OAs |
|---|---|
| GN Corporation Co Ltd | 3 |
| Jammit, Inc. | 1 |
| Turion Corporation | 1 |
| NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY | 1 |
| Sophy Inc. | 1 |
| Jbm Incorporation | 1 |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1634 | 2 |
| 2118 | 1 |
| 2458 | 1 |
| 1632 | 1 |
| 1638 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18780967 | USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS | Jammit, Inc. | MERCADO VARGAS, ARIEL | 2118 | §112DP | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18766372 | Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction | Turion Corporation | COX, NATISHA D | 2458 | §112 | Non-Final OA | 70d | Pending | Jul 08, 2024 |
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | National University Corporation Kochi University | BRANDSEN, BENJAMIN MICHAEL | 1693 | §101§102§112DP | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18027892 | CELL POPULATION PRODUCTION METHOD | Gn Incorporation Co. Ltd. | TAKENAKA, RISA | 1632 | §102§103§112 | Final Rejection | — | Pending | Mar 22, 2023 |
| 18001994 | BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE | Sophy Inc. | HIBSHMAN, SARAH GRACE | 1693 | §102§103§112 | Final Rejection | — | Pending | Dec 15, 2022 |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | Gn Corporation Co. Ltd. | TINSLEY, BRENDAN THOMAS | 1634 | §102§103§112 | Final Rejection | — | Pending | Aug 19, 2022 |
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | Gn Corporation Co. Ltd. | ROGERS, ERIC JASON | 1638 | §102§112 | Final Rejection | 112d overdue | Pending | Aug 17, 2022 |
| 17601861 | CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY | Jbm Incorporation | PENNINGTON, KATIE LEIGH | 1634 | Other | Non-Final OA | — | Pending | Oct 06, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial90.1% of resolved applications prosecuted by Syndicated Law Pc were allowed, across 386 applications in USPTO records.
2.78 office actions per allowed application on average.
8 pending office actions as of October 2026, for 6 clients, before 8 examiners in 6 art units.